Non-Vascular Approach: Offers a safe alternative for those who may have contraindications with traditional vasodilator medications
[15] Without adequate data and regulatory authorization, BPC-157 should remain described as a laboratory research peptide rather than a therapeutic agent
Cells were spun at 4C for 20 min to pellet, and resuspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH = 8)
148, 29632972.CrossRefGoogle ScholarPubMed Han, VK, Lund, PK, Lee, DC, DErcole, AJ
There were no deaths or patients needing respiratory support, and changes in lung function and other functional and muscle measures were not significantly different between groups
Clinical Medicine 87(9):52-55